Efficacy and Safety of Deferiprone in Patients With Parkinson's Disease
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
The New England Journal of Medicine
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Trial of Deferiprone in Parkinson's Disease
N. Engl. J. Med 2022 Dec 01;387(22)2045-2055, D Devos, J Labreuche, O Rascol, JC Corvol, A Duhamel, P Guyon Delannoy, W Poewe, Y Compta, N Pavese, E Růžička, P Dušek, B Post, BR Bloem, D Berg, W Maetzler, M Otto, MO Habert, S Lehericy, J Ferreira, R Dodel, C Tranchant, A Eusebio, S Thobois, AR Marques, WG Meissner, F Ory-Magne, U Walter, RMA de Bie, M Gago, D Vilas, J Kulisevsky, C Januario, MVS Coelho, S Behnke, P Worth, K Seppi, T Ouk, C Potey, C Leclercq, R Viard, G Kuchcinski, R Lopes, JP Pruvo, P Pigny, G Garçon, O Simonin, J Carpentier, AS Rolland, D Nyholm, C Scherfler, JF Mangin, M Chupin, R Bordet, DT Dexter, C Fradette, M Spino, F Tricta, S Ayton, AI Bush, JC Devedjian, JA Duce, I Cabantchik, L Defebvre, D Deplanque, C MoreauFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.